Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination therapy is effective and well-tolerated for treating esophageal cancer.

JAK inhibitors show promise in treating difficult skin diseases.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Finasteride increases CD8+ T cells in BPH tissues.

The man's skin condition improved with sun protection and topical steroids, but UV exposure still caused flare-ups.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Using tamsulosin with finasteride is the most effective and reduces surgery risk for BPH.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

4-aminopyridine helps heal burn wounds faster by reducing inflammation and promoting new blood vessel growth.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

JAK inhibitors are effective for long-term management of alopecia areata.

Some blood pressure medications are linked to a higher risk of skin cancer.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Certain cancer drugs can cause skin issues like rashes and itching.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.